A phase I dose finding study of oral TNO155 in adult patients with advanced solid tumors
CTNO155X2101
Phase 1 other active
Quick answer
A phase I dose finding study of oral TNO155 in adult patients with advanced solid tumors for Advanced solid tumors is a Phase 1 program (other) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Advanced solid tumors
- Phase
- Phase 1
- Modality
- other
- Status
- active